Teva Pharmaceutical Industries Limited
$35.86
$0.51(1.44%)
Teva Pharmaceutical Industries Limited
TEVA
$35.86
$0.51(1.44%)
Teva Pharmaceutical Industries Limited
TEVA
NYSE
$35.86
$0.51(1.44%)
Chart
Upcoming Earnings
Next report date
Jul 29, 2026
Report period
Q3 2026
EPS Estimate
$0.60
Revenue Estimate
$4.06B
Key stats
52-Week Range$35.86
$14.99
$37.35
Market capitalization
$41.76BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
25.71Basic EPS (TTM)
$1.24Net income (TTM)
$1.41BRevenue (TTM)
$17.26BAvg. volume
6.84MBeta (1Y)
0.86Employees
37.00KMarket capitalization
$41.76BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
25.71Basic EPS (TTM)
$1.24Net income (TTM)
$1.41BRevenue (TTM)
$17.26BAvg. volume
6.84MBeta (1Y)
0.86Employees
37.00KScreener Quick Check
Sign in to check this stock against your screeners
Sign InAbout Teva Pharmaceutical Industries Limited
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Richard D. Francis
Website
www.tevapharm.comHeadquarters
124 Dvora Hanevi'a Street, Tel Aviv, 6944020
IPO Date
1982-02-16
Identifiers
ISIN
US8816242098Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines,...
Related Stocks
$206.77
1D:
-2.3%
1Y:
31.4%
US6323071042Healthcare
Mkt Cap
$29.31B
P/E Ratio TTM
-136.1
Revenue TTM
$2.31B
Beta
1.68
Earnings TTM
$-208.16M
Dividend Yield TTM
0.00%
$175.30
1D:
4.2%
1Y:
10.9%
US09062X1037Healthcare
Mkt Cap
$25.72B
P/E Ratio TTM
20.1
Revenue TTM
$9.81B
Beta
0.16
Earnings TTM
$1.29B
Dividend Yield TTM
0.00%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate